Frontiers in Medicine · Nov 9, 2026
Maternal serum 25-hydroxyvitamin D status and OGTT-defined gestational glucose dysregulation in Southwest China: a hospital-based cross-sectional study
By Xueqin Xiang, Xiaoqing Yin, Wenbin Zhan et al.
Background: The association of maternal vitamin D status with gestational diabetes mellitus (GDM) and oral glucose tolerance test (OGTT) abnormalities may differ across glycemic presentations. We examined these associations in a hospital-based antenatal population. Methods: This hospital-based cross-sectional study included 3,024 pregnant women in Southwest China. Serum 25-hydroxyvitamin D [25(OH)D] was measured by enzyme-linked immunosorbent assay at a median gestational age of 12.8 weeks; OGTT was performed at a median of 25.8 weeks. Multivariable logistic regression assessed GDM, OGTT components, vitamin D categories, dose– response associations, BMI interaction, and sensitivity analyses. Results: GDM was diagnosed in 426 women (14.1%). Women with GDM had lower mean 25(OH)D than women without GDM (21.61 ± 6.11 vs. 25.18 ± 6.35 ng/mL). In 2,786 complete cases, the adjusted OR for GDM per 5 ng/mL increase was 0.63 (95% CI 0.56–0.71), compared with 0.57 (0.51–0.63) when BMI was omitted from the adjusted model. The inverse association was stronger among women with obesity than among those with underweight/normal weight (P for interaction = 0.008). The strongest component-specific association was observed for fasting abnormality (OR 0.58, 95% CI 0.50–0.68). Spline visualization showed a graded inverse association, without clear evidence that a nonlinear specification improved model fit. Sensitivity analyses showed similar associations. Conclusions: Lower maternal 25(OH)D was associated with GDM and OGTT-defined glucose abnormalities, especially fasting abnormalities. The earlier timing of vitamin D measurement does not establish a causal relationship. Further research is needed to assess clinical utility and clarify confounding.